Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 23:9:1027674.
doi: 10.3389/fmed.2022.1027674. eCollection 2022.

Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model

Affiliations

Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model

Elly Mertens et al. Front Med (Lausanne). .

Abstract

Objectives: To adopt a multi-state risk prediction model for critical disease/mortality outcomes among hospitalised COVID-19 patients using nationwide COVID-19 hospital surveillance data in Belgium.

Materials and methods: Information on 44,659 COVID-19 patients hospitalised between March 2020 and June 2021 with complete data on disease outcomes and candidate predictors was used to adopt a multi-state, multivariate Cox model to predict patients' probability of recovery, critical [transfer to intensive care units (ICU)] or fatal outcomes during hospital stay.

Results: Median length of hospital stay was 9 days (interquartile range: 5-14). After admission, approximately 82% of the COVID-19 patients were discharged alive, 15% of patients were admitted to ICU, and 15% died in the hospital. The main predictors of an increased probability for recovery were younger age, and to a lesser extent, a lower number of prevalent comorbidities. A patient's transition to ICU or in-hospital death had in common the following predictors: high levels of c-reactive protein (CRP) and lactate dehydrogenase (LDH), reporting lower respiratory complaints and male sex. Additionally predictors for a transfer to ICU included middle-age, obesity and reporting loss of appetite and staying at a university hospital, while advanced age and a higher number of prevalent comorbidities for in-hospital death. After ICU, younger age and low levels of CRP and LDH were the main predictors for recovery, while in-hospital death was predicted by advanced age and concurrent comorbidities.

Conclusion: As one of the very few, a multi-state model was adopted to identify key factors predicting COVID-19 progression to critical disease, and recovery or death.

Keywords: Belgium; COVID-19; hospital data; multistate modelling; risk prediction model.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic representation of the multi-state model with four states and five transition events, including the event matrix for training and Testing set. aNo event represents censored or absorbing state. bTraining set was taken in 10-fold for building the prediction model on stacked multiple-imputed data. cTesting set for calculating prediction error includes complete cases only (excluding 57% of the Testing patients with missing data on any of the predicting variables).
FIGURE 2
FIGURE 2
Prediction error of the multi-state prediction model as compared with a null model, calculated using the Brier score, overall (A) and stratified by state (B).
FIGURE 3
FIGURE 3
Plots for the cumulative transition hazards (A) and state-occupation probabilities (B) in a multi-state model considering a high-risk patient (tick solid line) versus a reference patient (thin solid line). The reference patient represents an average patient characterised by being male, aged between 55 and 69 years old, admitted to a general hospital with a medium-high ICU occupancy at hospital admission, experiencing lower respiratory complaints, having zero co-morbidities, being a non-smoker, and presenting high levels of lymphocyte and medium-high levels (Q3) of lactate dehydrogenase (LDH) and C-reactive protein (CRP). The high-risk patient represents an existing patient with the worst risk profile, while having the same age, sex, hospital type and ICU occupancy at admission as the reference patient.
FIGURE 4
FIGURE 4
Nomograms to predict the transition probability for admission to recovery (A), ICU (B), and in-hospital death (C) after 2, 3, 7, and 14 days of hospitalisation in COVID-19 hospitalised COVID-19 patients. Patients’ values are located on the axis of each variable where 0 refers to “No” and 1 “Yes”; drawing an upward line at 90° angle to determine the number of points for that particular variable. The sum of these numbers of points is located on the total score axis; drawing a downward line at 90° angle to determine the probability of experiencing that particular transition at day 2, 3, 7, and 14.

References

    1. Sciensano. COVID-19 Epidemiologische Situatie. Brussel: Sciensano; (2021).
    1. Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal. BMJ. (2020) 369:m1328. - PMC - PubMed
    1. Lu J, Hu S, Fan R, Liu Z, Yin X, Wang Q, et al. ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China. medRxiv [Preprint]. (2020). 10.1101/2020.02.20.20025510 - DOI
    1. Wang S, Zha Y, Li W, Wu Q, Li X, Niu M, et al. A Fully automatic deep learning system for COVID-19 diagnostic and prognostic analysis. Eur Respir J. (2020) 56:2000775. 10.1183/13993003.00775-2020 - DOI - PMC - PubMed
    1. Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. medRxiv [Preprint]. (2020). 10.1101/2020.04.20.20072223 - DOI - PMC - PubMed